Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A Single Dose of Oral BCG Moreau Fails to Boost Systemic IFN-γ Responses to Tuberculin in Children in the Rural Tropics: Evidence for a Barrier to Mucosal Immunization.

Vaca M, Moncayo AL, Cosgrove CA, Chico ME, Castello-Branco LR, Lewis DJ, Cooper PJ.

J Trop Med. 2012;2012:132583. doi: 10.1155/2012/132583. Epub 2012 Jan 11.

2.

Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination.

Clark SO, Kelly DL, Badell E, Castello-Branco LR, Aldwell F, Winter N, Lewis DJ, Marsh PD.

Vaccine. 2010 Oct 8;28(43):7109-16. doi: 10.1016/j.vaccine.2010.07.087. Epub 2010 Aug 12.

PMID:
20708695
3.

Relationship between bacille Calmette-Guérin vaccination, Mantoux test positivity, and geohelminth infection.

Cooper PJ, Chico ME, Gaus D, Griffin GE.

Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):473-6.

PMID:
15259485
4.
5.

Environmental determinants of total IgE among school children living in the rural Tropics: importance of geohelminth infections and effect of anthelmintic treatment.

Cooper PJ, Alexander N, Moncayo AL, Benitez SM, Chico ME, Vaca MG, Griffin GE.

BMC Immunol. 2008 Jun 27;9:33. doi: 10.1186/1471-2172-9-33.

6.

Persistence of the immune response induced by BCG vaccination.

Weir RE, Gorak-Stolinska P, Floyd S, Lalor MK, Stenson S, Branson K, Blitz R, Ben-Smith A, Fine PE, Dockrell HM.

BMC Infect Dis. 2008 Jan 25;8:9. doi: 10.1186/1471-2334-8-9.

7.

Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCG Moreau Rio de Janeiro (RDJ) in healthy adults.

Monteiro-Maia R, Ortigão-de-Sampaio MB, Pinho RT, Castello-Branco LR.

J Immune Based Ther Vaccines. 2006 Sep 6;4:4.

8.

Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.

Hosseini M, Dobakhti F, Pakzad SR, Ajdary S.

Scand J Immunol. 2015 Dec;82(6):489-97. doi: 10.1111/sji.12351.

9.

Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR.

Cooper PJ, Chico ME, Losonsky G, Sandoval C, Espinel I, Sridhara R, Aguilar M, Guevara A, Guderian RH, Levine MM, Griffin GE, Nutman TB.

J Infect Dis. 2000 Oct;182(4):1199-206. Epub 2000 Sep 8.

PMID:
10979918
11.

Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.

Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.

Vaccine. 2009 Jan 1;27(1):28-37. doi: 10.1016/j.vaccine.2008.10.034. Epub 2008 Oct 31.

PMID:
18977269
12.

Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells.

Akkoc T, Aydogan M, Yildiz A, Karakoc-Aydiner E, Eifan A, Keles S, Akin M, Kavuncuoglu S, Bahceciler NN, Barlan IB.

Pediatr Allergy Immunol. 2010 Nov;21(7):1059-63. doi: 10.1111/j.1399-3038.2010.01051.x.

PMID:
20977501
13.

BCG vaccination in India and tuberculosis in children: newer facets.

Udani PM.

Indian J Pediatr. 1994 Sep-Oct;61(5):451-62. Review.

PMID:
7744445
15.

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

Skinner MA, Buddle BM, Wedlock DN, Keen D, de Lisle GW, Tascon RE, Ferraz JC, Lowrie DB, Cockle PJ, Vordermeier HM, Hewinson RG.

Infect Immun. 2003 Sep;71(9):4901-7.

16.

Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.

Schepers K, Dirix V, Mouchet F, Verscheure V, Lecher S, Locht C, Mascart F.

Vaccine. 2015 Feb 18;33(8):1077-83. doi: 10.1016/j.vaccine.2014.12.011. Epub 2015 Jan 9.

PMID:
25583385
17.

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.

Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM.

Lancet. 2002 Apr 20;359(9315):1393-401.

PMID:
11978337
18.

A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge.

Cai H, Yu DH, Hu XD, Li SX, Zhu YX.

DNA Cell Biol. 2006 Aug;25(8):438-47.

PMID:
16907641
19.

Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics.

Cooper PJ, Chico ME, Rodrigues LC, Ordonez M, Strachan D, Griffin GE, Nutman TB.

J Allergy Clin Immunol. 2003 May;111(5):995-1000.

PMID:
12743563
20.

Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea.

Lee H, Cho SN, Kim HJ, Anh YM, Choi JE, Kim CH, Ock PJ, Oh SH, Kim DR, Floyd S, Dockrell HM.

Vaccine. 2011 Sep 2;29(38):6564-71. doi: 10.1016/j.vaccine.2011.07.003. Epub 2011 Jul 18.

PMID:
21763746

Supplemental Content

Support Center